Skip to main content

Table 2 Dose-limiting toxicities per dose level

From: Prospective, open, multi-centre phase I/II trial to assess safety and efficacy of neoadjuvant radiochemotherapy with docetaxel and oxaliplatin in patients with adenocarcinoma of the oesophagogastric junction

 

Dose level

 
 

1

2

3

Total

Number of patients

4 (100%)

13 (100%)

7 (100%)

24 (100%)

Any DLTs?

    

  No

3 (75%)

12 (92%)

2 (29%)

17 (71%)

  Yes

1 (25%)

1 (8%)

5 (71%)

7 (29%)

If yes:

    

CTC-Grade

III

IV

III

IV

III

IV

 

Non-haematological toxicity grade ≥ 3:

      

6 (25%)

 - Dehydration, syncope

1

      

 - Heartburn/dyspepsia

     

1

 

 - Fatigue

    

2

  

 - Diarrhea

    

1

  

 - Infection

    

1

  

Haematological toxicity:

      

1 (4%)

 - Thrombocytpenia

   

1

   
  1. DLT, dose limiting toxicity.